TABLE 2.
Assay format | Combined assay targets | Sample selection criterion | No. of samples tested | Commercial availability | Description | Reference(s) |
---|---|---|---|---|---|---|
Multiplex real–time PCRa | E. histolytica, C. parvum sensu lato,l G. lamblia, and PhHV | Microscopy–positive stool samples | 112 | In–house | First multiplex real–time PCR described for detection of diarrhea–causing protozoa; has been adapted in many diagnostic laboratories since then | 79 |
Multiplex PCR array | E. histolytica, E. dispar, Cryptosporidium, and G. lamblia | Control DNA only | In-house | Simultaneous detection, species differentiation, and genotyping after hybridization of a multiplex PCR in a microarray format | 447 | |
Multiplex real-time PCRb | G. lamblia, Cryptosporidium, and E. histolytica | Antigen- and PCR-positive stool samples | 129 | In-house | Primers designed from the COWP gene should be able to detect C. parvum, C. hominis, and C. meleagridis but not other species of Cryptosporidium | 448 |
Multiplex real-time PCRc | E. histolytica, C. parvum sensu lato, G. lamblia, and PhHV | Gastrointestinal complaints | 956 | In-house | Higher detection rates found for Giardia and Cryptosporidium with PCR, and no additional parasites found with microscopy in a general practitioner patient population | 104 |
Multiplex real-time PCR | N. americanus, A. duodenale, O. bifurcum, and PhHV | No selection, population based | 339 | In-house | Good correlation found between DNA load and egg/larval counts | 328 |
Multiplex real-time PCRd | E. histolytica, C. parvum sensu lato, G. lamblia, and PhHV; S. stercoralis and PhHV | Stool samples from travelers | 2,591 | In-house | PCR for the targets used outperformed expert microscopy; strikingly, even in travelers, not many additional parasites were found by microscopy | 107 |
Multiplex real-time PCRd,e | E. histolytica, C. parvum sensu lato, G. lamblia, and PhHV; D. fragilis and PhHV | Stool samples from patients with gastrointestinal complaints | 397 | In-house | Increased detection rate of D. fragilis with PCR (31%) compared to that with microscopy (17%) | 27 |
Multiplex real-time PCRb | G. lamblia, Salmonella enterica, Campylobacter jejuni, and PhHV | Stool samples from patients with gastrointestinal complaints | 13,974 | In-house | Implementation of Giardia PCR in a routine diagnostic laboratory | 106 |
Multiplex real-time PCRf,g | A. duodenale, N. americanus, A. lumbricoides, S. stercoralis, and PhHV | No selection, population based | 1,312 | In-house | Large albendazole placebo-controlled trial on the effect of STH infections on allergy, atherosclerosis, and malaria; effect of treatment was monitored by quantitative real-time PCR | 319, 321, 333, 449 |
Multiplex nested PCR-RFLP | Microsporidia, Cyclospora, and Cryptosporidium | Controls | In-house | Conventional and nested PCR are not very practical in a routine setting | 450 | |
Multiplex tandem real-time PCR | E. histolytica, Cryptosporidium, G. lamblia, and D. fragilis | Stool samples from patients with gastrointestinal complaints | 472 | AusDiagnostics, Beaconsfield, Australia | Automated system of multiplex preamplification followed by target-specific real-time PCR | 451 |
Multiplex PCR using Luminex beadsb,f,g,h,i | E. histolytica, Cryptosporidium, G. lamblia, A. duodenale, N. americanus, A. lumbricoides, and S. stercoralis | Microscopy- and/or PCR-positive stool samples | 319 | In-house | Luminex detection of multiplex PCR products using primers and probes that were described previously as real-time TaqMan-based assays | 322 |
Multiplex PCR using Luminex beads | C. cayetanensis, C. belli, E. bieneusi, and E. intestinalis | Microscopy- and/or PCR-positive stool samples | 234 | In-house | Luminex detection of multiplex PCR products using primers and probes that were described previously as real-time TaqMan-based assays | 193 |
Multiplex real-time PCRf,g,h | A. duodenale, N. americanus, A. lumbricoides, S. stercoralis, and PhHV | Stool samples from patients with gastrointestinal complaints | 78 | In-house | Application of multiplex real-time PCR in Malaysia for STH infection, finding higher detection rates with PCR, especially for A. lumbricoides and S. stercoralis | 320 |
Multiplex real-time PCRc,e,j | E. histolytica, E. dispar, C. parvum sensu lato, and G. lamblia; E. bieneusi and Encephalitozoon spp.; D. fragilis; Blastocystis | HIV positive | 96 | In-house | Although a high prevalence of intestinal parasites was detected, there was no association between any of the parasites and the presence of diarrhea | 160 |
Multiplex tandem real-time PCR | Campylobacter, Clostridium difficile, Salmonella, Cryptosporidium, G. lamblia, Shigella, adenovirus 40/41, and norovirus | Cryptosporidium-positive samples and negative-control samples | 267 | AusDiagnostics | Extension of the no. of targetsn | 452 |
Multiplex real-time PCRc,f,g,h | E. histolytica, Cryptosporidium, and G. lamblia; A. duodenale, N. americanus, A. lumbricoides, and S. stercoralis | Stool samples from patients with gastrointestinal complaints | 229 | In-house | Application of multiplex real-time PCR in Malaysia for STHs and diarrhea-causing protozoa | 161 |
Multiplex PCR | E. histolytica, astrovirus, calicivirus, and EIEC | Stool samples from patients with gastrointestinal complaints | 103 | In-house | Conventional PCR is not very practical in a routine setting with large numbers of samples | 453 |
Multiplex real-time PCRc,e | E. histolytica, C. parvum sensu lato, and G. lamblia; E. dispar; D. fragilis | Stool samples from patients with gastrointestinal complaints | 889 | In-house | PCR showed higher detection rates of the parasites targeted; no additional pathogens were found by FECT-microscopy | 162 |
TaqMan open array | Cryptosporidium, G. lamblia, Campylobacter spp., Clostridium difficile, Salmonella, Vibrio parahaemolyticus, diarrheagenic Escherichia coli (EHEC), Shigella, Yersinia enterocolitica, Listeria monocytogenes, adenovirus, astrovirus, norovirus GI, norovirus GII, rotavirus, and sapovirus | Stool samples from patients with gastrointestinal complaints | 86 | In-house | A DNA sample with PCR mix is distributed by hydrophilic forces into 64 through-holes, in which primers and a probe are spotted by the manufacturer; in this way, up to 64 PCRs per sample can be performed for 48 samples simultaneously | 87, 454 |
Multiplex real-time PCRd | E. histolytica, C. parvum sensu lato, G. lamblia, and PhHV | Stool samples from patients with gastrointestinal complaints | 396 | In-house | Microscopy showed low sensitivity and specificity compared to real-time PCR, especially for detection of E. histolytica | 87 |
TaqMan array card | Cryptosporidium, G. lamblia, Ascaris lumbricoides, Trichuris trichiura Campylobacter jejuni-C. coli, Clostridium difficile, Salmonella, Vibrio cholerae, diarrheagenic Escherichia coli (EAEC, ETEC, EPEC, and STEC), Shigella/EIEC, adenovirus, astrovirus, norovirus GII, rotavirus, sapovirus, and PhHV | Microscopy-, culture-, and/or immunoassay-positive stool samples | 109 | In-house | A DNA sample with PCR mix is distributed by centrifugation into 42 wells of a microfluidic card in which primers and probe are spotted by the manufacturer | 309 |
TaqMan panelf,i | E. histolytica, Cryptosporidium, G. lamblia, A. duodenale, N. americanus, A. lumbricoides, S. stercoralis, and T. trichiura | No selection, population based | 525 | In-house | Parallel testing of 8 singleplex PCR mixtures that were prealiquoted and stored frozen until use; good correlation between egg counts and DNA load; all Ascaris PCR-positive cases tested negative 3 wk after treatment | 18 |
Multiplex real-time PCR | E. histolytica, Cryptosporidium, and G. lamblia; Campylobacter coli-C. jejuni, E. coli (VTEC), Salmonella spp., Shigella spp., E. coli (EIEC), Y. enterocolitica, and C. difficile; norovirus GI, norovirus GII, and IC; adenovirus, astrovirus, and rotavirus | Stool samples from patients with gastrointestinal complaints | 1,758 | CE labeled (Fast-Track Diagnostics, Luxembourg) | Enhanced rate of detection of diarrhea-causing pathogens using a broad approach due to more sensitive detection of pathogens and detection of pathogens that were not requested | 413 |
Multiplex PCR using Luminex beads | E. histolytica, Cryptosporidium, G. lamblia, Salmonella spp., Shigella spp., Campylobacter spp., E. coli O157, ETEC, STEC, C. difficile, Y. enterocolitica, V. cholerae, norovirus GI, norovirus GII, adenovirus 40/41, and rotavirus A | Stool samples from patients with gastrointestinal complaints | 901 | FDA cleared, CE labeled (Luminex) | Multicenter study comparing standard routine procedures including culture, antigen tests, and real-time PCR with Luminex detection of multiplex PCR products of 15 viral, bacterial, and parasitic pathogens (Luminex xTAG GPP) | 423 |
Multiplex PCR using Luminex beads | E. histolytica, Cryptosporidium, G. lamblia, Salmonella spp., Shigella spp., Campylobacter spp., E. coli O157, ETEC, STEC, C. difficile, Y. enterocolitica, V. cholerae, norovirus GI, norovirus GII, adenovirus 40/41, and rotavirus A | Stool samples from diarrheic patients | 440 | FDA cleared, CE labeled (Luminex) | Luminex xTAG GPP was compared with standard routine procedures which did not include real-time PCR; no further analysis of discrepant results | 422 |
Multiplex PCR using Luminex beads | E. histolytica, Cryptosporidium, G. lamblia, Salmonella spp., Shigella spp., Campylobacter spp., E. coli O157, ETEC, STEC, C. difficile, Y. enterocolitica, V. cholerae, norovirus GI, norovirus GII, adenovirus 40/41, rotavirus A | Stool samples from patients with gastrointestinal complaints | 393 | FDA cleared, CE labeled (Luminex) | Luminex xTAG GPP was compared to standard routine procedures including culture, antigen tests, and real-time PCR; 5 of 6 E. histolytica-positive results by xTAG GPP could not be confirmed | 455 |
Multiplex real-time PCRf,g,j,k | A. duodenale, N. americanus, A. lumbricoides, S. stercoralis, and PhHV; Schistosoma and PhHV | Stool samples from HIV-positive patients | 153 | In-house | Improved detection of helminth infections using real-time PCR; discrepancies in risk factor analysis between qualitative data from PCR and microscopy; this was resolved by using quantitative data from PCR | 456 |
PCR primers and probe for Cryptosporidium are described in reference 158.
PCR primers and probe for Giardia are described in reference 79.
PCR primers and probes for E. histolytica, Cryptosporidium, and Giardia are described in reference 79.
PCR primers and probes for E. histolytica and Giardia are described in reference 79.
PCR primers and probe for D. fragilis are described in reference 128.
PCR primers and probes for N. americanus and A. duodenale are described in reference 328.
PCR primers and probe for S. stercoralis are described in reference 354.
PCR primers and probe for A. lumbricoides are described in reference 319.
PCR primers and probe for E. histolytica are described in reference 448.
PCR primers and probes for E. bieneusi and Encephalitozoon spp. are described in reference 457.
PCR primers and probe for Schistosoma are described in reference 458.
Nomenclature of the sequence from GenBank used for the design of primers and probes was for C. parvum, which was later separated into C. hominis and C. parvum.
Abbreviations: RFLP, restriction fragment length polymorphism; SSU, small subunit; ITS, internal transcribed spacer; STH, soil-transmitted helminth; GPP, gastrointestinal pathogen panel; COWP, Cryptosporidium oocyst wall protein; FECT, formol ethyl-acetate concentration technique; EIEC, enteroinvasive Escherichia coli; EHEC, enterohemorrhagic E. coli; EAEC, enteroaggregative E. coli; ETEC, enterotoxigenic E. coli; EPEC enteropathogenic E. coli; STEC, Shiga-toxigenic E. coli; VTEC, verotoxin-producing Escherichia coli; IC, internal control; CE, European Community; PhHV, phocine herpesvirus.
As described in reference 451.